While context varies largely amongst the cultural use of psychoactive substances, the core concept of tripsitting remains: to safeguard and provide guidance to those under the influence of psychoactive substances, principally if it’s their first experience with a particular substance.
TripSitter.Clinic mentioned in The New York Times piece, "The Ketamine Cure", a survey of at-home ketamine therapy clinics that are broadening access to breakthrough depression therapy.
Dr. John Huber featured in High Times on the recent ballot box win for Detroit, Michigan to decriminalize the possession and therapeutic use of entheongenic plants.
Newsy sat down with Dr. John Huber (CEO, Tripsitter Clinic) to discuss the trauma that directly and indirectly effects children and adolescents after acts of violence occur in our schools.
In-depth interview series, Authority Magazine, profiled TripsStter.Clinic CEO, Dr. John Huber in a recent piece titled "Health Tech: Dr John Huber On How TripSitter.Clinic’s Technology Can Make An Important Impact On Our Overall Wellness".
The psychedelics community has ben eagerly awaiting results from the Phase 3 clinical trial of MDMA-assisted treatment of PTSD. The results are finally in and to call them promising would be an understatement.
While more investments in research are needed, the treatment of methamphetamine addiction through a tailored program of ketamine therapy could make a dent in tackling nearly 40 year old epidemic.
As I reflect back on the remarkable journey undertaken by a past patient in the face of severely debilitating OCD, I'm still amazed by the demonstrated power that Ketamine has to quell obstructive thought loops and all-consuming worry.
A decade ago, people began steadily following the science of ketamine therapy. Fast forward to today and ketamine is positioned within the thriving global market.
TripSitter.Clinic was brought to life by experienced mental health physicians and psychedelics advocates who share a professional and personal stake in helping to evolve the state of mental health care. This is our story.
Many people claim that ketamine is not a psychedelic, but what does the research say? Learn more about the unique pathway ketamine works in the brain and why ketamine should be considered a psychedelic compound.
TripSitter.Clinic was brought to life by experienced mental health physicians and psychedelics advocates who share a professional and personal stake in helping to evolve the state of mental health care. This is our story.
A decade ago, people began steadily following the science of ketamine therapy. Fast forward to today and ketamine is positioned within the thriving global market.
As I reflect back on the remarkable journey undertaken by a past patient in the face of severely debilitating OCD, I'm still amazed by the demonstrated power that Ketamine has to quell obstructive thought loops and all-consuming worry.
While more investments in research are needed, the treatment of methamphetamine addiction through a tailored program of ketamine therapy could make a dent in tackling nearly 40 year old epidemic.
The psychedelics community has ben eagerly awaiting results from the Phase 3 clinical trial of MDMA-assisted treatment of PTSD. The results are finally in and to call them promising would be an understatement.
TripSitter.Clinic mentioned in The New York Times piece, "The Ketamine Cure", a survey of at-home ketamine therapy clinics that are broadening access to breakthrough depression therapy.
Newsy sat down with Dr. John Huber (CEO, Tripsitter Clinic) to discuss the trauma that directly and indirectly effects children and adolescents after acts of violence occur in our schools.
